{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T13:04:56Z","timestamp":1765112696169},"reference-count":23,"publisher":"BMJ","issue":"6546","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1986,8,30]]},"DOI":"10.1136\/bmj.293.6546.533","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"533-536","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of rhesus immunisation after genetic amniocentesis."],"prefix":"10.1136","volume":"293","author":[{"given":"A","family":"Tabor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Jerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"48","article-title":"Fetal-maternal bleeding associated with genetic amniocentesis","volume":"SS:","author":"Mennuti, M.T.; Brummond, W.; Crombleholme, W.R.; Schwarz, R.H.; Aryan, D.A.","year":"1980","unstructured":"Mennuti MT, Brummond W, Crombleholme WR, Schwarz RH, Aryan DA. Fetal-maternal bleeding associated with genetic amniocentesis. Obstet Gynecol 1980;SS:48-54.","journal-title":"Obstet Gynecol"},{"key":"ref_2","first-page":"389","article-title":"Campbell 5, Craft I. Risks of fetomaternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization","volume":"46","author":"Harrison, R.","year":"1975","unstructured":"Harrison R, Campbell 5, Craft I. Risks of fetomaternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization. Obstet Gynecol 1975;46:389-91.","journal-title":"Obstet Gynecol"},{"key":"ref_3","first-page":"41","article-title":"Fetal blood group studies during mid-trimester pregnancy and the management of severe isoimmunization","volume-title":"Prenat Diagn","volume":"3","author":"Mackenzie, I.; Guest, C.M.; Bowell, P.J.","year":"1983","unstructured":"Mackenzie I, Guest CM, Bowell PJ. Fetal blood group studies during mid-trimester pregnancy and the management of severe isoimmunization. Prenat Diagn 1983;3:41-6."},{"key":"ref_4","article-title":"Prevention of Rh sensitization. WHO Tech Rep Ser 1971, No 468","author":"World Health Organisation","unstructured":"World Health Organisation. Prevention of Rh sensitization. WHO Tech Rep Ser 1971, No 468."},{"key":"ref_5","first-page":"854","article-title":"Turnover rate of anti-D IgG injected during pregnancy","volume":"284","author":"Eklund, J.; Hermann, M.; Kjelmann, H.; Pohja, P.","year":"1982","unstructured":"Eklund J, Hermann M, Kjelmann H, Pohja P. Turnover rate of anti-D IgG injected during pregnancy. BrMedJ7 1982;284:854-5.","journal-title":"BrMedJ7"},{"key":"ref_6","first-page":"3093","article-title":"Rhesus immnunization. A review from the east Danish region during the period 1976-1981","volume":"144","author":"Tabor, A.; Block, J.E.; Jacobsen, J.C.","year":"1982","unstructured":"Tabor A, Block JE, Jacobsen JC. Rhesus immnunization. A review from the east Danish region during the period 1976-1981. UgeskrLaeger 1982;144:3093-5.","journal-title":"UgeskrLaeger"},{"key":"ref_7","first-page":"50","article-title":"McMaster conference on prevention of Rh immunization","volume":"36","author":"Davey, M.G.; Zipuraky, A.","year":"1979","unstructured":"Davey MG, Zipuraky A. McMaster conference on prevention of Rh immunization. Vox Sang 1979;36:50-64.","journal-title":"Vox Sang"},{"key":"ref_8","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman, J.M.; Chown, B.; Lewis, M.; Pollock, J.M.","year":"1978","unstructured":"Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can MedAssocJ7 1978;118:623-7."},{"key":"ref_9","first-page":"149","article-title":"Rh isoimmunization following genetic amniocentesis","volume":"2","author":"Golbus, M.S.; Stephens, J.D.; Cann, H.M.; Mann, J.; Hensleigh, P.A.","year":"1982","unstructured":"Golbus MS, Stephens JD, Cann HM, Mann J, Hensleigh PA. Rh isoimmunization following genetic amniocentesis. PrenasDiagn 1982;2: 149-56.","journal-title":"PrenasDiagn"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ajmg.1320160411","article-title":"Rh isoimmunization related to amniocentesis","volume":"16","author":"Murray, J.C.; Karp, L.E.; Wiliamson, R.A.; Cheng, E.Y.; Luthy, D.A.","year":"1983","unstructured":"Murray JC, Karp LE, Wiliamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. AmJ Med Genet 1983;16:527-34.","journal-title":"AmJ Med Genet"},{"key":"ref_11","first-page":"327","article-title":"Maternal anti-D concentratiosssandoutcome in rhesus haemnolytic diseas of the newborn","volume":"285","author":"Boweli, P.; WainscoatJS, PetoTEA; Gunson, H.H.","year":"1982","unstructured":"Boweli P, WainscoatJS, PetoTEA, Gunson HH. Maternal anti-D concentratiosssandoutcome in rhesus haemnolytic diseas of the newborn. BrMedJ 1982;285:327-9.","journal-title":"BrMedJ"},{"key":"ref_12","first-page":"915","article-title":"Fetal erythrocytes in the maternal circulation of pregnant women","volume":"23","author":"Clayton, E.M.; Feldhaus, W.D.; Whitacre, F.E.","year":"1964","unstructured":"Clayton EM, Feldhaus WD, Whitacre FE. Fetal erythrocytes in the maternal circulation of pregnant women. Obsut Gyuece 1964;23:915-9.","journal-title":"Obsut Gyuece"},{"key":"ref_13","first-page":"225","article-title":"Risks of prophylactic anti-D immunoglobulin after wecond-trinmesteramnoce tei","volume":"149","author":"Tabsh, K.M.A.; Leblserz, T.B.; Crnmdail, B.F.","year":"1994","unstructured":"Tabsh KMA, Leblserz TB, Crnmdail BF. Risks of prophylactic anti-D immunoglobulin after wecond-trinmesteramnoce tei. AwlJObssetGyxseoJ 1994;149:225-6.","journal-title":"AwlJObssetGyxseoJ"},{"issue":"30","key":"ref_14","volume":"293","author":"MEDICAL, B.R.I.T.I.S.H.","year":"1986","unstructured":"BRITISH MEDICAL JOURNAL VOLumE 293 30 AuGusTr 1986","journal-title":"JOURNAL"},{"key":"ref_15","first-page":"153","article-title":"Rh immunization facilitated by passively-admnisstered anti-Rh?","volume":"53","author":"Contreras, M.; Moution, P.L.","year":"1983","unstructured":"Contreras M, Moution PL. Rh immunization facilitated by passively-admnisstered anti-Rh?BrJ Haexsani 1983;53:153-9.","journal-title":"BrJ Haexsani"},{"key":"ref_16","first-page":"289","article-title":"Controveries in Rh prophylaxis. Who needs Rh imnmuneglobuhn and whenshould it begiven?","volume":"151","author":"Bowman, J.M.","year":"1985","unstructured":"-Bowman JM. Controveries in Rh prophylaxis. Who needs Rh imnmuneglobuhn and whenshould it begiven?Amj ObstwGyueco 1985;151:289-94","journal-title":"Amj ObstwGyueco"},{"key":"ref_17","first-page":"1085","article-title":"Antibody suppression and antialiotype antibodies. H. Interference of circulatory antiallotypeantibodieswith prophylactive treatnmentagainst Rh snitizaion","volume":"5","author":"Jemne, D.","year":"1976","unstructured":"Jemne D. Antibody suppression and antialiotype antibodies. H. Interference of circulatory antiallotypeantibodieswith prophylactive treatnmentagainst Rh snitizaion. ScaudJlwaamod 1976;5:1085-9.","journal-title":"ScaudJlwaamod"},{"key":"ref_18","author":"Accepted I3Jume 1986)","unstructured":"(Accepted I3Jume 1986)"},{"key":"ref_19","article-title":"In addition to the cases described above, by August 1985 the WHO centre had received%reports of skin reactions associated with terfenadine, from the United Kingdom (89 cases), Belgum (four), Canada (two), and the Federal Republic of Germany (one). Sixty seven patients were female (mean age 34 (rnmge 4-80)) and 29 male (mean age 37(5-77)). Forty three patients developed a rash, described as erythematous in eigt cases and maculopapular in 11; 32 patients developed urticaria; and the rming21 reports included six cases ofangio-oedema, five of photosensitivity reaction, adfour of peeling of the skin of the hands or feet, or both. One patient had extensive circinate and confluent erythema that proceeded to desquamation and recurred on rechallenge","unstructured":"In addition to the cases described above, by August 1985 the WHO centre had received%reports of skin reactions associated with terfenadine, from the United Kingdom (89 cases), Belgum (four), Canada (two), and the Federal Republic of Germany (one). Sixty seven patients were female (mean age 34 (rnmge 4-80)) and 29 male (mean age 37(5-77)). Forty three patients developed a rash, described as erythematous in eigt cases and maculopapular in 11; 32 patients developed urticaria; and the rming21 reports included six cases ofangio-oedema, five of photosensitivity reaction, adfour of peeling of the skin of the hands or feet, or both. One patient had extensive circinate and confluent erythema that proceeded to desquamation and recurred on rechallenge."},{"issue":"79","key":"ref_20","article-title":"The latent period between first intake of the drug and the onset of the reaction was known in 72 casesand wasless thanthreedaysin 35 case and less thana week in 50. The mean latent period of rashes was 8-25 days, of urticaria 14-6 days, and ofphotosensitivity reactions 39 days. Outcome was favourable in 60 cases and not stated in 23; 13 patients had not yet recovered. Of those patients for whom the indication and dosage were reported","volume-title":"took terfenadine for hay fever or nasopharyngitis, most taking 120 mg\/day by mouth. In 31 reports use of other drugs was mentioned (mainly oral contraceptives), but these either were continued uneventfully or had been used for a long time without problems. Eleven of the 89 patients reported to the Committee on Safety of Medicines (CSM) (all confirmed by us by reference to the original reports) reacted on challenge","volume":"22","year":"1985","unstructured":"The latent period between first intake of the drug and the onset of the reaction was known in 72 casesand wasless thanthreedaysin 35 case and less thana week in 50. The mean latent period of rashes was 8-25 days, of urticaria 14-6 days, and ofphotosensitivity reactions 39 days. Outcome was favourable in 60 cases and not stated in 23; 13 patients had not yet recovered. Of those patients for whom the indication and dosage were reported, 22 (79%) took terfenadine for hay fever or nasopharyngitis, most taking 120 mg\/day by mouth. In 31 reports use of other drugs was mentioned (mainly oral contraceptives), but these either were continued uneventfully or had been used for a long time without problems. Eleven of the 89 patients reported to the Committee on Safety of Medicines (CSM) (all confirmed by us by reference to the original reports) reacted on challenge. After August 1985, 14 additional cases were reported to the CSM."},{"key":"ref_21","article-title":"Allergic contat demnatistifom opicaidruigs. Unwaxuted effects ofcosmetic and drugs used in dernatoior","author":"NaterJP, deGrootAC","unstructured":"NaterJP, deGrootAC. Allergic contat demnatistifom opicaidruigs. Unwaxuted effects ofcosmetic and drugs used in dernatoior. 2nded. Amsterdam: Elsevier, 1985:44.","edition":"2"},{"key":"ref_22","article-title":"Cutaneous side effects ofsystemic drugs","author":"Zfircher, K.; Krebs, A.","year":"1980","unstructured":"Zfircher K, Krebs A. Cutaneous side effects ofsystemic drugs. Basle: Karger, 1980:193."},{"key":"ref_23","first-page":"224","article-title":"Pseudo-allergic reactions due to histamine releaseduring intravenous anaesthesia","volume-title":"Pseudo-allrgic reactions. Involvemen of drugs and chemicals","author":"Doenicke, A.","year":"1980","unstructured":"Doenicke A. Pseudo-allergic reactions due to histamine releaseduring intravenous anaesthesia. In: Dukor P, Kall6s P, Schiumberger HD, West GB, eds. Pseudo-allrgic reactions. Involvemen of drugs and chemicals. Basle: Karger, 1980:224-50."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.293.6546.533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:06:28Z","timestamp":1601064388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.293.6546.533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,8,30]]},"references-count":23,"journal-issue":{"issue":"6546","published-print":{"date-parts":[[1986,8,30]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.293.6546.533","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,8,30]]}}}